Beyond Publications: What Medical Experts Told Us About Scientific Impact

At ScienceLeadR, we believe scientific impact cannot be reduced to one metric. Publications still matter. However, they are only part of the picture. Medical experts also shape science through trial leadership, funding, innovation, editorial roles, and expert discussion.

To understand this better, ScienceLeadR ran a survey on scientific impact assessment. The results show that healthcare professionals prefer a broader and more balanced view of expert impact. They do not rely on publications alone.

1. Publications and citations remain a core signal, but not the only one

When asked whether publications and citations reflect the scientific impact of a medical expert, 66.66% of respondents agreed or strongly agreed. Specifically, 22.22% strongly agreed and 44.44% agreed. Another 22.22% were neutral, while 11.11% strongly disagreed.

This confirms that publications and citations remain foundational. They are still the most visible and standardised way to evaluate scientific contribution. A strong publication record shows that an expert contributes to the formal scientific literature, while citations indicate that their work is being used by others.

However, the result also shows that publications are not universally accepted as a complete measure of impact. The presence of neutral and strongly negative responses suggests that some healthcare professionals see limitations in relying too heavily on bibliometric indicators.

For ScienceLeadR, this supports a balanced approach: publications and citations should remain central to scientific impact assessment, but they should be interpreted alongside other evidence-based signals.

2. Clinical trial activity is one of the strongest indicators of real-world scientific impact

The clearest signal in the survey concerned clinical trials.

When asked whether clinical trials led or contributed to reflect the scientific impact of a medical expert, 100% of respondents to that item agreed or strongly agreed: 50% strongly agreed and 50% agreed.

Clinical trial involvement reflects a type of impact that publication metrics often miss. A principal investigator does not only contribute intellectually. They help translate scientific hypotheses into clinical evidence. They work with patients, sites, protocols, ethics requirements, sponsors, and multidisciplinary teams. In many therapeutic areas, trial leadership is one of the most practical indicators that an expert is actively shaping the future of care.

This has direct implications for expert assessment. A medical expert who leads or contributes to major clinical trials should not be evaluated only through publication count. Their trial role, trial phase, disease area, recruitment responsibility, and principal investigator status all matter.

3. Grants and research funding matter, but interpretation is more nuanced

Responses on grants and research funding were more divided. When asked whether grants and research funding obtained reflect the scientific impact of a medical expert, 50% agreed and 50% disagreed among respondents to that item.

This split is important. It suggests that funding is recognised as meaningful, but not automatically equivalent to scientific impact.

There are good reasons for both views. On one hand, obtaining competitive funding usually reflects peer recognition, scientific credibility, institutional trust, and the ability to lead a research programme. On the other hand, grant acquisition can be influenced by geography, institutional resources, seniority, access to funding networks, and national funding structures.

The implication is that grants should be included in scientific impact assessment, but with caution. Funding should not be treated as a simple “more money equals more impact” metric. It should be interpreted in context: role of the expert, competitiveness of the grant, funding body, research topic, career stage, and whether the funding generated publications, trials, datasets, or clinical advances.

4. Congress activity is not seen as uniformly equivalent to scientific impact

The survey showed a mixed view of congress and conference activity. When asked whether talks at congresses and conferences reflect scientific impact, responses were evenly split: 33.33% agreed, 33.33% were neutral, and 33.33% disagreed.

This suggests that congress activity is not automatically perceived as scientific impact. Its value depends heavily on the role, the venue, and the scientific context.

The distinction between speaker and session chair is especially useful. For a speaker at an international congress, respondents were split between considering the role equivalent to a medium-impact-factor publication and a lower-impact-factor publication. For a session chair, the perceived value was higher: 50% considered it equivalent to a high-impact-factor publication, and 50% considered it equivalent to a medium-impact-factor publication.

For ScienceLeadR, the takeaway is clear: congress activity should not be counted as a flat metric. The platform should distinguish between poster presenter, invited speaker, faculty member, session chair, guideline presenter, and congress committee role. These are not equivalent signals.

5. Patents and innovation are recognised, but not always as traditional scientific impact

When asked whether patents and innovations reflect scientific impact, 50% of respondents strongly agreed, while 50% were neutral.

This suggests that innovation is seen as relevant, but not always easy to compare with academic outputs. The publication-equivalence question showed the same pattern. For a patent or innovation as lead inventor, 50% considered it equivalent to a medium-impact-factor publication, and 50% considered it equivalent to a lower-impact-factor publication.

This indicates that patents and innovations should be included in a multidimensional assessment, especially in fields such as medtech, diagnostics, digital health, biotechnology, and translational medicine. However, they should be interpreted differently from publications.

6. Academic society and journal editor roles reflect trust — but may not be directly comparable to publications

Academic society positions and journal editor roles were viewed positively, though not universally. When asked whether academic society or journal editor positions reflect scientific impact, 50% agreed and 50% were neutral.

The publication-equivalence question revealed an even more interesting split. For a journal editor or major academic society board position, 50% of respondents considered it equivalent to a high-impact-factor publication, while 50% selected “not comparable.”

This is one of the most useful findings in the survey. It suggests that some experts see society and editorial positions as very high-value signals of scientific leadership. Others do not believe they should be translated into publication-equivalent value at all.

Both interpretations are valid. Editorial and society roles represent peer trust, governance, agenda-setting, and influence over standards. But they are not the same type of output as a publication. They do not necessarily generate new data, but they shape how data is reviewed, interpreted, prioritised, and disseminated.

7. Mentorship is valued inconsistently — but should not be ignored

Mentorship and training produced a divided response: 50% agreed that it reflects scientific impact, while 50% disagreed.

This split likely reflects a measurement problem rather than a lack of importance. Mentorship is one of the most important ways scientific influence is transmitted across generations. Senior experts shape the field not only through their own work, but through the researchers, clinicians, fellows, PhD students, and trial leaders they train.

However, mentorship is difficult to measure objectively. Unlike publications or trials, it is often not captured in public databases. It can be informal, institution-specific, or invisible outside a department.

8. Social media is the most nuanced signal

The survey produced two different signals on social media.

When asked whether social media influence and outreach reflect the scientific impact of a medical expert, 100% of respondents to that item selected neutral. This suggests caution. The community does not appear to reject social media entirely, but it also does not clearly endorse it as a direct marker of scientific impact.

However, when asked how important social media should be in a scientific impact assessment, responses were more positive: 50% selected “moderate weight” and 50% selected “equal weight to traditional metrics.”

This creates an important distinction. Social media may not be accepted as scientific impact in itself. Follower count, posting frequency, or visibility alone should not be treated as scientific authority. But digital engagement may matter when it is connected to evidence: commenting on publications, discussing clinical trial data, explaining guideline changes, or contributing to professional scientific debate.

9. Community visibility should be controlled, but not overly closed

The survey also asked about how comments on scientific articles and news should be visible on the ScienceLeadR platform.

Responses were split between two options: 50% preferred comments to be visible to all connected members by default, while 50% preferred visibility only to connected members in the same specialty. No respondents selected visibility only to direct network members, and no respondents selected “no preference.”

This is an important product insight. It suggests that healthcare professionals are open to scientific dialogue beyond their immediate personal network, but they still expect a professional and relevant environment.

What these findings mean for scientific impact assessment

Taken together, the survey points toward one clear conclusion: scientific impact cannot be measured by a single score or one dominant metric.

• Publications and citations: still foundational, with 66.66% agreement or strong agreement.
• Clinical trial leadership: one of the strongest signals, with 100% agreement or strong agreement among respondents to that item.
• Congress activity: relevant, but role-dependent; session chair roles were valued more highly than standard speaker roles.
• Grants and funding: important but context-sensitive, with divided views.
• Patents and innovation: meaningful, especially for translational fields, but not directly equivalent to publications.
• Academic society and journal editor positions: important leadership signals, but not always comparable to publication metrics.
• Social media and digital engagement: potentially useful when evidence-anchored, but risky if reduced to popularity or reach.

This is exactly why ScienceLeadR is building an evidence-first, transparent approach to expert assessment. The goal is not to replace human judgement with a black-box algorithm. The goal is to make scientific contribution more visible, more structured, and more fairly represented.

From survey insight to algorithm design

A human-first approach to scientific intelligence

ScienceLeadR’s ambition is to help life sciences stakeholders identify and engage the right experts through transparent, evidence-based intelligence.

But scientific impact is not only a data problem. It is also a community problem. The way impact is measured should reflect how medical experts themselves understand contribution, leadership, and influence.

This survey is an early step in that dialogue. It shows that the community still values traditional indicators such as publications and citations, but also recognises the importance of clinical trials, academic leadership, innovation, grants, and professional engagement.

As ScienceLeadR continues to grow, we will continue to integrate feedback from healthcare professionals into our methodology. Our goal is to build AI solutions that remain human-first: transparent, evidence-based, and aligned with how the scientific community actually recognises impact.

Scientific impact is not a single number.

It is a structured record of how experts generate evidence, lead research, shape clinical practice, train others, and move science forward.

That record deserves to be measured with nuance.